Table 5.
KIR | Ligands | Frequency | |
---|---|---|---|
Patients | Controls | ||
KIR2DL2/2DL3 | HLA-CAsn80 | 7 (38.9%) | 3 (18.8%) |
KIR2DL1 | HLA-CLys80 | 3 (60.0%) | 11 (68.8%) |
KIR2DL1; KIR2DL2/2DL3 | HLA-CLys80;Asn80 | 12 (46.2%) | 7 (33.3%) |
KIR | Ligands | Frequency | |
---|---|---|---|
Patients | Controls | ||
KIR2DL2/2DL3 | HLA-CAsn80 | 7 (38.9%) | 3 (18.8%) |
KIR2DL1 | HLA-CLys80 | 3 (60.0%) | 11 (68.8%) |
KIR2DL1; KIR2DL2/2DL3 | HLA-CLys80;Asn80 | 12 (46.2%) | 7 (33.3%) |